Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography–negative chemical ionization–mass spectrometry

This publication has 13 references indexed in Scilit:

• Pharmacokinetics and metabolism of intravenous midazolam in preterm infants
  Clinical Pharmacology & Therapeutics, 2001
• The Single‐Dose Pharmacokinetics of Midazolam and Its Primary Metabolite in Pediatric Patients after Oral and Intravenous Administration
  The Journal of Clinical Pharmacology, 2001
• Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes
  Pharmacogenetics, 2000
• Sensitive and specific determination of midazolam and 1-hydroxymidazolam in human serum by liquid chromatography–electrospray mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1999
• Analysis of Midazolam and Metabolites in Plasma by High-Performance Liquid Chromatography: Probe of CYP3A
  Therapeutic Drug Monitoring, 1998
• Simultaneous determination of midazolam and its metabolites 1-hydroxymidazolam and 4-hydroxymidazolam in human serum using gas chromatography–mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• Rifampin drastically reduces plasma concentrations and effects of oral midazolam
  Published by Wiley ,1996
• First-pass metabolism of midazolam by the human intestine*
  Clinical Pharmacology & Therapeutics, 1995
• Noninvasive tests of CYP3A enzymes
  Pharmacogenetics, 1994
• Pharmacokinetics and bioavailability of midazolam in man.
  British Journal of Clinical Pharmacology, 1983